Abstract:In the author's institution, 2254 patients with hepatocellular carcinoma (HCC) have been treated during 1958-1994. The overall 5-year survival increased from 5.4% (1958-1970), to 11.9% (1971-1982), to 46.2% (1983-1984), which correlated well with the increasing proportion of small HCC in the series (2.6%, 12.1%, and 33.4%, respectively); with the increasing percentage of limited resection (3.1%, 32.2%, and 58.3%); with the increasing number of re-resections for recurrence (0, 27, and 114 patients); and with the increasing number of second stage resections (0, 5, and 67 patients). In our institution, surgical approaches that resulted in significantly prolonging survival included: small HCC resection, re-resection, and cytoreduction followed by sequential resection for initially unresectable HCC. Experience in these 3 aspects suggests: (a) Small HCCs are mainly found by screening using AFP and ultrasonography (US) in a high risk population, and limited resection is the best treatment in patients with compensated liver cirrhosis, the 5-year survival after resection being 62.9% (n = 549). (b) Postoperative monitoring using AFP/US every 2-3 months for 5-10 years after curative resection is needed to detect subclinical recurrence. Limited re-resection is indicated for liver recurrence less than 3 nodules, and lung lobectomy is of proven merit to prolong survival for solitary lung metastasis. Re-resection of subclinical recurrence has resulted in a 10-20% further increase in 5-year survival after curative resection. (c) Palliative surgery other than resection such as hepatic artery ligation (HAL) and cannulation with arterial infusion (HAI), cryosurgery, etc. are superior to palliative resection with residual cancer. (d) Cytoreduction and sequential resection have provided hope for localized unresectable HCC, particularly in the right cirrhotic liver. Multimodality combination treatments such as HAL+HAI+radioimmunotherapy/regional radiotherapy are acceptable cytoreductive therapies. Repeated transcatheter hepatic arterial chemoembolization (TACE) is an alternative nonsurgical approach. Sequential resection is important to eradicate residual cancer after cytoreduction. The 5-year survival of 72 patients with cytoreduction and sequential resection for initially unresectable HCC was 62.1% and resulted in improving 5-year survival in the entire series of unresectable HCC over the 3 periods from 0% to 7.4% to 25.7%, respectively. However, multicentric origin and tumor invasiveness are two major targets to be studied in the control of recurrence and metastasis.

Recurrence after Resection of Alpha-Fetoprotein-Positive Hepatocellular-Carcinoma

Surgical Treatment of Recurrent Hepatocellular Carcinoma.

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

[Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma]

Extrahepatic recurrence after curative resection of hepatocellular cancer

Risk Factors and Prognosis of Patients with Recurrent Hepatocellular Carcinoma Who Undergo Liver Re-Resections.

Risk Factors Associated with Early and Late Recurrence after Curative Resection of Hepatocellular Carcinoma: a Single Institution's Experience with 398 Consecutive Patients.

Clinical Features of Recurrence after Hepatic Resection for Early-stage Hepatocellular Carcinoma and Long-term Survival Outcomes of Patients with Recurrence - A Multi-institutional Analysis Contained 1424 Cases

Predictors and Long-Term Prognosis of Early and Late Recurrence for Patients Undergoing Hepatic Resection of Hepatocellular Carcinoma: a Large-Scale Multicenter Study

Early Intrahepatic Recurrence of Hepatocellular Carcinoma after Hepatectomy Treated with Re-Hepatectomy, Ablation or Chemoembolization: a Prospective Cohort Study.

Risk Factors, Patterns, and Outcomes of Late Recurrence after Liver Resection for Hepatocellular Carcinoma: A Multicenter Cohort Study in 734 Patients over 15 Years

Risk factors, patterns and outcomes of late recurrence after liver resection for patients with hepatocellular carcinoma: analysis of a multicenter cohort over 15 years

Risk Factors for Early Recurrence of Small Hepatocellular Carcinoma after Curative Resection.

Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience

Treatment of Recurrence Following Surgery for Primary Liver Cancer:A Report of 58 Cases

Three Decades' Experience In Surgery Of Hepatocellular Carcinoma

A Case-Control Study of Correlation Between Preoperative Serum Afp and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy

Therapeutic Effect of Repeated Hepatectomy on 48 Cases of Recurrent Hepatocellular Carcinoma and Prognostic Factors

Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular Carcinoma

Changes in Serum Alpha Fetoprotein in Patients with Recurrent Hepatocellular Carcinoma Following Hepatectomy.

Risk Factors and Management for Early and Late Intrahepatic Recurrence of Solitary Hepatocellular Carcinoma after Curative Resection.